4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-19-019332
EVP, North America Commercial sold 738 shares at $15.67 ($11,568)
- EVP, North America Commercial acquired 738 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
O'Grady Brendan P. · EVP, North America Commercial
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-03-12 | Exercise or conversion : show line 1 in the form | +738 | 2,126.49 | D | ||
| 2019-03-12 | Sale : show line 2 in the form | −738 | $15.67 | $11,568 | 1,388.49 | D |
| Open-market sales · 738 sh · avg $15.67 · $11,568 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-03-12 | Exercise or conversion : show line 3 in the form Restricted Share Units | −738 | 0 | D |
Loading xslF345X03/doc4.xml…